Followers | 30 |
Posts | 2429 |
Boards Moderated | 0 |
Alias Born | 02/18/2005 |
Wednesday, July 01, 2020 10:50:49 AM
Narayanan studying application of brilacidin for treatment of coronavirus infections
GEORGE MASON UNIVERSITY
Aarthi Narayanan, Associate Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections.
Brilacidin is an investigational new drug. It is a polymer-based antibiotic currently in human clinical trials. It represents a new class of antibiotics called host defense protein mimetics, or HDP-mimetics, which are non-peptide synthetic small molecules modeled after host defense peptides.
As part of this project, Narayanan will first determine the EC50 values, or the concentration of the drug that gives a half-maximal response.
From there, Naryanan and her collaborators will evaluate if Brilacidin has direct virus-killing activity.
They will also assess whether Brilacidin can be provided as a second dose to infected cells without inducing toxicity.
As they work, the researchers will time their experiments to determine the appropriate timing of treatment.
Funding for this research began in May 2020 and will conclude in late August 2020.
https://www.eurekalert.org/pub_releases/2020-06/gmu-nsa060520.php
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM